Derek Lowe
Contributor since: 2007
Latest Articles
Bristol-Myers Squibb And Celgene
Worse Than Useless
More On BAN2401, Unfortunately
The Cancer Stem Cell Saga
The Dark Side Of A Wonderful Investment Story
Sangamo's Gene Therapy Results
PAINS Filters In The Real World
Biogen And Eisai: Let The Alzheimer's Arguing Commence
Biogen And Eisai Tease An Alzheimer's Result
Alzheimer's And Infectious Disease: For Real
Welcome To Right To Try
Gene Therapy For Duchenne
Finger-Pointing At Celgene
An Alzheimer's Statement
More Thoughts On AbbVie's Rova-T Implosion
Merck's BACE-Inhibitor Alzheimer's Wipeout
IDO Appears To Have Wiped Out
4-Azidophenylalanine: A Warning
Bad Investments
IDO Inhibitors Hit A Wall
Thoughts On Compound Collections
Zap The Zinc
Where's All That Money Going? (Pharma Edition)
Way Down There In The Pores
Tetraphase And Their Troubles
Cost Of Trials
The Next Immuno-Oncology Frontier?
Bristol-Myers Squibb Sows Confusion
Brute Force: Bring On The Machines
Pay Your Money And Hold Your Breath
A New Look At Clinical Success Rates
Inhaled Nanoparticles - Good Ones, That Is